These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6305470)

  • 1. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
    Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
    Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
    [No Abstract]   [Full Text] [Related]  

  • 3. Uncertainties in the management of the Zollinger-Ellison Syndrome.
    Malagelada JR
    Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
    [No Abstract]   [Full Text] [Related]  

  • 4. Ranitidine and cimetidine in Zollinger-Ellison syndrome.
    Mignon M; Vallot T; Mayeur S; Bonfils S
    Br J Clin Pharmacol; 1980 Aug; 10(2):173-4. PubMed ID: 6107118
    [No Abstract]   [Full Text] [Related]  

  • 5. Ranitidine: a new H2-receptor antagonist.
    Berner BD; Conner CS; Sawyer DR; Siepler JK
    Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Landor JH
    N Engl J Med; 1980 Oct; 303(16):942-3. PubMed ID: 6251369
    [No Abstract]   [Full Text] [Related]  

  • 7. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome.
    Howard TJ; Passaro E
    Surg Annu; 1990; 22():93-106. PubMed ID: 2408174
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 9. Ranitidine--pharmacology and clinical use.
    Dawson J; Richards DA; Stables R; Dixon GT; Cockel R
    J Clin Hosp Pharm; 1983 Mar; 8(1):1-13. PubMed ID: 6132928
    [No Abstract]   [Full Text] [Related]  

  • 10. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
    Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
    Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
    Helman CA; Tim LO
    Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ranitidine and cimetidine in Zollinger-Ellison syndrome].
    Ribera E; González-Atienza J
    Med Clin (Barc); 1983 Dec; 81(20):924-5. PubMed ID: 6319838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cimetidine, ranitidine and somatostatin in the medical treatment of acute and chronic Zollinger-Ellison syndrome].
    Gordillo J; Varas MJ
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):749-50. PubMed ID: 2894045
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of metastatic Zollinger-Ellison syndrome with high-dose H2-receptor antagonists.
    Johnston SR; Wright PL
    Br J Clin Pract; 1990 Dec; 44(12):792-3. PubMed ID: 2102253
    [No Abstract]   [Full Text] [Related]  

  • 15. Zollinger-Ellison syndrome unresponsive to cimetidine.
    Groarke JF; Haggstrom GD; Halpern NB; Hirschowitz BI
    Am J Gastroenterol; 1979 Aug; 72(2):168-70. PubMed ID: 474557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
    Vallot T; Mignon M; Mazure R; Bonfils S
    Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
    Stabile BE; Ippoliti AF; Walsh JH; Passaro E
    Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome.
    de Gara CJ; Gledhill T; Hunt RH
    Can Med Assoc J; 1984 Mar; 130(5):550, 554. PubMed ID: 6321004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.